| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 05/09/2000 | US6060294 Alanyl tRNA synthetase from Staphylococcus aureus |
| 05/09/2000 | US6060280 Nucleotide sequences encoding bovine respiratory syncytial virus immunogenic proteins |
| 05/09/2000 | US6060278 Expressing recombinant human troponin c and t and a modified recombinant troponin i, then complexing by mixing in neutral ph, aqueous medium in presence of alkaline salt(s); for controls/calibrators in diagnosis of myocardial infarction |
| 05/09/2000 | US6060259 Having molecular weight in presence of sodium dodecyl sulfate of between 44.5 and 47.5 kilodaltons; for detecting or monitoring the development of tuberculosis in man or cattle |
| 05/09/2000 | US6060257 Tumor rejection antigens presented by HLA-B44 molecules, and uses thereof |
| 05/09/2000 | US6060250 Human transferases |
| 05/09/2000 | US6060082 Phospholipid bilayer having covalently bonded phospholipids, an aqueous core and a lectin wherein the lectin is ulex europeans agglutinin i. |
| 05/09/2000 | US6060068 Human IL-2 as a vaccine adjuvant |
| 05/09/2000 | US6060067 Process for the preparation of tetanus toxoid vaccine |
| 05/09/2000 | US6060066 First unit containing ricin toxoid vaccine and adjuvant and a second unit comprising a tumor-killing effective amount of ricin in sterile saline. |
| 05/09/2000 | US6060065 Compositions for inhibition of membrane fusion-associated events, including influenza virus transmission |
| 05/09/2000 | US6060064 Chimeric virus-like particle antigen presentation and delivery system |
| 05/09/2000 | US6060059 Haemophilus adhesion proteins |
| 05/09/2000 | US6060058 Vaccine for conferring bacterial immunity containing lactoferrin receptor protein |
| 05/09/2000 | US6060057 Cloning and sequencing of allergens of Dermatophagoides (house dust mite) |
| 05/09/2000 | US6060056 Composition for inducing humoral anergy to an immunogen comprising a T cell epitope-deficient analog of the immunogen conjugated to a nonimmunogenic valency platform molecule |
| 05/09/2000 | US6060055 Inducing immunological response in a mammal which comprises delivering a nucleic acid vector to direct expression of div1b polypeptide for expressing said div1b polypeptide in vivo |
| 05/09/2000 | US6060049 Surrogate tolerogenesis for the development of tolerance to xenografts |
| 05/09/2000 | CA2100586C Htlv-i and htlv-ii peptide antigens and methods |
| 05/09/2000 | CA2058940C Targeted liposomes and methods for liposome-protein coupling |
| 05/09/2000 | CA2057860C Immunoactive peptides and antibodies and their use in anti-allergy treatment |
| 05/04/2000 | WO2000024913A2 Mn gene and protein |
| 05/04/2000 | WO2000024902A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 05/04/2000 | WO2000024901A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 05/04/2000 | WO2000024897A1 Cell surface molecule-induced macrophage activation |
| 05/04/2000 | WO2000024896A2 Biological material for preparing pharmaceutical compositions for treating mammals |
| 05/04/2000 | WO2000024890A1 Novel g protein-coupled receptor proteins, dnas thereof and ligands to the same |
| 05/04/2000 | WO2000024886A1 Prv-1 gene and the use thereof |
| 05/04/2000 | WO2000024876A2 Spumavirus isolated from humans |
| 05/04/2000 | WO2000024781A1 Conformation-specific anti-von willebrand factor antibodies |
| 05/04/2000 | WO2000024778A1 Hla-a2 and hla-dr specific peptide epitopes from the melanoma antigen trp2 |
| 05/04/2000 | WO2000024777A1 Antigenic epitopes with lym-1 reactivity and uses thereof |
| 05/04/2000 | WO2000024773A2 Inhibition of transglutaminase-mediated microbial infection of a mammalian host |
| 05/04/2000 | WO2000024771A2 Nucleic acids encoding osteoprotegerin-like proteins and methods of using same |
| 05/04/2000 | WO2000024766A2 New transcription factor of mhc class ii genes, substances capable of inhibiting this new transcription factor and medical uses of these substances |
| 05/04/2000 | WO2000024765A2 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 05/04/2000 | WO2000024754A1 infB POLYPEPTIDE AND POLYNUCLEOTIDES OF STREPTOCOCCUS PNEUMONIAE |
| 05/04/2000 | WO2000024428A2 Cationic lipid-mediated enhancement of nucleic acid immunization of cats |
| 05/04/2000 | WO2000024420A1 Method for the production of an antiviral agent |
| 05/04/2000 | WO2000024406A1 A method of activating t cells and agents useful for same |
| 05/04/2000 | WO2000006743A3 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 05/04/2000 | WO2000006733A3 T cell receptor proteins, nucleic acid molecules, and uses thereof |
| 05/04/2000 | WO2000006730A3 Human cytoskeletal proteins |
| 05/04/2000 | WO2000002917A3 Compounds and methods for modulating cadherin-mediated functions |
| 05/04/2000 | WO2000002897B1 Delta cleavage products and methods based thereon |
| 05/04/2000 | WO2000000614A3 NOVEL ANTIGENS OF $i(HELICOBACTER PYLORI) |
| 05/04/2000 | WO1999067283A8 Two-kinase domain mitogen- and stress-activated protein kinases and uses thereof |
| 05/04/2000 | WO1999063988A9 Inhibitors of nitric oxide synthase |
| 05/04/2000 | WO1999052944A8 G-protein coupled receptors |
| 05/04/2000 | WO1999051781A9 Hepatitis c virus ns5b compositions and methods of use thereof |
| 05/04/2000 | DE19916085A1 Antiviral agent, e.g. for treating HIV infections, comprising autovaccine obtained by heating blood containing viruses and antigens with protein crosslinking agent |
| 05/04/2000 | CA2349211A1 Prv-1 gene and the use thereof |
| 05/04/2000 | CA2348989A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 05/04/2000 | CA2348840A1 Method for the production of an antiviral agent |
| 05/04/2000 | CA2348827A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 05/04/2000 | CA2348747A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 05/04/2000 | CA2347983A1 Inhibition of transglutaminase-mediated microbial infection of a mammalian host |
| 05/04/2000 | CA2347294A1 Novel g protein coupled receptor protein, dna and its ligand |
| 05/04/2000 | CA2347293A1 Nucleic acids encoding osteoprotegerin-like proteins and methods of using same |
| 05/04/2000 | CA2347068A1 New transcription factor of mhc class ii genes, substances capable of inhibiting this new transcription factor and medical uses of these substances |
| 05/04/2000 | CA2344606A1 Conformation-specific anti-von willebrand factor antibodies |
| 05/04/2000 | CA2344207A1 Biological material for preparing pharmaceutical compositions for treating mammals |
| 05/03/2000 | EP0997529A2 Feline immunodeficiency virus strain FIV-141 and uses thereof |
| 05/03/2000 | EP0997477A2 MHC complexes and uses thereof |
| 05/03/2000 | EP0997476A2 Antibodies to a mammalian Langerhans cell antigen and their uses |
| 05/03/2000 | EP0997152A1 Remedies for lymphocytic tumors |
| 05/03/2000 | EP0996857A2 Cancer associated nucleic acids and polypeptides |
| 05/03/2000 | EP0996733A1 Phosphatidylinositol 4,5-bisphosphate 5-phosphatase from human |
| 05/03/2000 | EP0996730A1 Nucleic acid vaccines encoding g protein of respiratory syncytial virus |
| 05/03/2000 | EP0996728A2 IMPROVED ANTI-IgE ANTIBODIES AND METHOD OF IMPROVING POLYPEPTIDES |
| 05/03/2000 | EP0996726A1 T-cell membrane protein (tirc7), peptides and antibodies derived therefrom and uses thereof |
| 05/03/2000 | EP0996723A1 Human phosphatidylinositol transfer protein gamma |
| 05/03/2000 | EP0996717A2 Immunoprotective influenza antigen and its use in vaccination |
| 05/03/2000 | EP0996712A2 Live attenuated vaccines |
| 05/03/2000 | EP0996710A1 Component of bromelain |
| 05/03/2000 | EP0996636A1 The ha-1 antigen |
| 05/03/2000 | EP0996635A1 Novel family of pheromone receptors |
| 05/03/2000 | EP0996634A1 Crystal of sm3 antibody (fragment) and recognizing epitope, its preparation, encoded data storage medium containing its coordinates and its diagnostical or medical use |
| 05/03/2000 | EP0996467A1 Txu-7-pap immunotoxin and use thereof |
| 05/03/2000 | EP0996464A1 Multivalent in ovo avian vaccine |
| 05/03/2000 | EP0996463A2 Catalytic monoclonal antibodies with protease activity for the selective lysis of the protein component of plaques and aggregates related to pathological conditions |
| 05/03/2000 | EP0996460A1 TREATMENT OF ACUTE LUNG INJURY AND FIBROSIS WITH ANTAGONISTS OF $g(a)v$g(b)6 |
| 05/03/2000 | EP0996455A1 $g(a)-O-LINKED GLYCOCONJUGATES WITH CLUSTERED (2,6)-ST EPITOPES, METHODS OF PREPARATION AND USES THEREOF |
| 05/03/2000 | EP0996451A1 Triterpene saponin analogs having adjuvant and immunostimulatory activity |
| 05/03/2000 | EP0996423A1 A method for producing jelly sweets which contain antibodies |
| 05/03/2000 | EP0862419B1 Microencapsulated dna for vaccination and gene therapy |
| 05/03/2000 | EP0688206B1 Vaccine delivery system and shelf-stable precursor solution for remote encapsulation of active ingredients |
| 05/03/2000 | EP0668908B1 Specific dna sequences of a nematode which can be used for the diagnosis of infection with the nematode |
| 05/03/2000 | EP0624100B1 Dna encoding a human serotonin receptor (5-ht 4b) and uses thereof |
| 05/03/2000 | EP0560947B1 Trivalent monospecific antigen binding proteins |
| 05/03/2000 | EP0514481B1 Merosin, nucleic acids encoding, fragments and uses thereof |
| 05/03/2000 | CN1252101A Component of bromelain |
| 05/03/2000 | CN1252096A Component of bromelain |
| 05/03/2000 | CN1252076A Production of antihuman antigen receptors and use thereof |
| 05/03/2000 | CN1252075A Synthetic HIV GAG genes |
| 05/03/2000 | CN1252002A Immunopotentiating formulations for vaccinal use |
| 05/03/2000 | CN1252000A Pharmaceutical compositions having appetite suppressant activity |
| 05/02/2000 | US6057436 Canine coronavirus S gene and uses therefor |
| 05/02/2000 | US6057435 Nucleic acid coding for polypeptide which binds to receptor tyrosine kinase containing immunoglobulin-like and epidermal growth factor homology domains expressed in vascular endothelial cells; diagnosis/imaging; angiogenesis inhibition |
| 05/02/2000 | US6057432 CysS |